AzTrials
AzTrials

Post Prandial Blood GlucoseNCT00728065

The Effects of Salvia Hispanica-Enriched Foods on Glycemic and Insulinemic Responses and Subjective Satiety

A study testing White Bread, White bread with added 7.32g Salvia hispanica and White bread with added 15.58g Salvia hispanica in people with Post Prandial Blood Glucose, run by Unity Health Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Salvia hispanic (Salba) is postulated to increase satiety. This study determines the optimal amount of Salba as well as whether liquid or solid enriched products will produce maximum satiety. The results can gauge the effectiveness of Salba in weight loss programs. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Post Prandial Blood Glucose
What is being tested?
White Bread, White bread with added 7.32g Salvia hispanica and White bread with added 15.58g Salvia hispanica
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteCanada
Study dates
Dec 2007to Feb 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • BMI 20-35 kg/m2

Who cannot join

  • Endocrine disease (adrenal disorders, glucose homeostasis disorders, metabolic bone diseases, pituitary gland disorders, parathyroid gland disorders, thyroid disorders)
  • Pregnancy
  • Use of drugs that influence carbohydrate metabolism (e.g. systemic glucocorticoids, beta blockers, thiazide diuretics)
  • Use of fiber supplements
  • Substance abuse (including regular smoking)
  • Digestive or malabsorption disorders (malabsorption syndrome, Crohn's disease, stomach ulcer, duodenal ulcer or intestinal parasites)
  • Presence of any significant disease or condition, including emotional or psychiatric disorders, that, in the opinion of the investigator, is likely to alter the metabolic state or interfere with the subject's ability to complete the study

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Clinical Nutrition and Risk Factor Modification Centre

    Toronto, Ontario, M5C 2T2

Other trials in Canada

About this study

Salvia hispanic (Salba) is postulated to increase satiety. This study determines the optimal amount of Salba as well as whether liquid or solid enriched products will produce maximum satiety. The results can gauge the effectiveness of Salba in weight loss programs. The study has a randomized, double-blind crossover design which includes 10 test meals and capillary blood sampling to perform glucose and insulin analyses (to determine blood glucose response and blood insulin response).

Read the detailed description

There are many factors that are involved in the ability of foods to suppress appetite, for instance the fiber, fat and protein contents of the food. The novel whole grain Salvia hispanica may significantly lower appetite compared to refined carbohydrates and other whole grains because of its composition. First, Salvia hispanica's high fiber content may help lower postprandial glycemia. Whole grains are much higher in fiber than refined carbohydrates. High fiber foods are thought to be more satiating because they have lower energy densities and delay gastric emptying, causing glucose to be released more slowly into the circulation. This, in turn, is hypothesized to increase satiety by preventing a sudden drop in blood glucose levels, which would normally trigger hunger . Another mechanism by which fiber may promote satiety, independent of glycemic responses, is through the secretion of gut hormones that signal fullness . Furthermore, Salvia hispanica may be more satiating than other whole grains due to its higher fat and protein contents. Protein and fat also prolong satiety due to mechanisms such as delayed gastric emptying and secretion of gut hormones .

Results from preliminary studies confirm the satiating effects of Salvia hispanica, as they demonstrate that this grain induces increased subjective satiety and reduced postprandial glycemia. It is presumed that if a food is satiating, it will decrease subsequent intake of other foods because hunger is suppressed. A lower caloric intake, in turn, would help promote weight loss.

Salvia hispanica may also encourage weight loss via another mechanism. Preliminary studies suggested that this grain has a lower glycemic index value than white flour. Consumption of low-GI foods compared to high-GI foods has been suggested to reduce obesity by discouraging fat deposition and promoting fat oxidation . Thus, Salvia hispanica could potentially promote weight loss by reducing both hunger and the amount of body fat stored.

In order to study Salvia hispanica's ability to promote weight loss, feasibility studies must first be done to determine what amount is optimal for satiety and also whether enriched products are most satiating in liquid or solid form.

Being tested
White Bread, White bread with added 7.32g Salvia hispanica, White bread with added 15.58g Salvia hispanica, White bread with added Salvia hispanica, Rice milk

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • White BreadDietary supplement

    About 100g of white bread consisting of 50g of available carbohydrates, served with 250mL water

  • White bread with added 7.32g Salvia hispanicaDietary supplement

    About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water

  • White bread with added 15.58g Salvia hispanicaDietary supplement

    About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water

  • White bread with added Salvia hispanicaDietary supplement

    About 100g of white bread consisting of 50g of available carbohydrates and 24g Salvia hispanica, served with 250mL water

  • Rice milkDietary supplement

    Rice milk containing 50g of available carbohydrates

  • Enriched rice milk containing 7.32g Salvia hispanicaDietary supplement

    Rice milk containing 50g of available carbohydrates with 7.32g added Salvia hispanica

  • Enriched rice milk containing 15.58g Salvia hispanicaDietary supplement

    Rice milk containing 50g of available carbohydrates with 15.58g added Salvia hispanica

  • Enriched rice milk containing 24g Salvia hispanicaDietary supplement

    Rice milk containing 50g of available carbohydrates with 24g added Salvia hispanica

Study groups in NCT00728065
Study groupRoleWhat they receive
1ExperimentalWhite Bread (control)
Receives: Dietary Supplement: White Bread
2ExperimentalWhite Bread (control)
Receives: Dietary Supplement: White Bread
3ExperimentalWhite bread with 7.32 grams Salba hispanica
Receives: Dietary Supplement: White bread with added 7.32g Salvia hispanica
4ExperimentalWhite bread with 15.58 grams Salba hispanica
Receives: Dietary Supplement: White bread with added 15.58g Salvia hispanica
5ExperimentalWhite bread with 24 grams Salba hispanica
Receives: Dietary Supplement: White bread with added Salvia hispanica
6ExperimentalRice Milk (control)
Receives: Dietary Supplement: Rice milk
7ExperimentalRice Milk (control)
Receives: Dietary Supplement: Rice milk
8ExperimentalRice Milk with 7.32 grams Salba hispanica
Receives: Dietary Supplement: Enriched rice milk containing 7.32g Salvia hispanica
9ExperimentalRice Milk with 15.58 grams Salba hispanica
Receives: Dietary Supplement: Enriched rice milk containing 15.58g Salvia hispanica
10ExperimentalRice Milk with 24 grams Salba hispanica
Receives: Dietary Supplement: Enriched rice milk containing 24g Salvia hispanica

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post prandial capillary blood glucose levels

    Measured: 2 hour period, Every 15 minutes for first hour, every 30 minutes for second hour

Secondary outcomes (1)
  1. Patient completed satiety questionnaire

    Measured: 2 hour period, Every 15 minutes for first hour, every 30 minutes for second hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2008 (estimated)
  2. Study startDec 2007
  3. Primary completionSep 2008
  4. Study completionFeb 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00728065
Sponsor's protocol ID
07-121
Status last verified
Feb 2009
First submitted
1 Aug 2008
Last updated
18 Feb 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing White Bread, White bread with added 7.32g Salvia hispanica and White bread with added 15.58g Salvia hispanica in people with Post Prandial Blood Glucose, run by Unity Health Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post prandial capillary blood glucose levels (time frame: 2 hour period, Every 15 minutes for first hour, every 30 minutes for second hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in